Image of Dr. Frankel and researchers at CRI

The Cancer Research Institute

One of the few institutes of its kind worldwide, linking new discoveries and clinical care.

The Cancer Research Institute, located within Temple's Health and Bioscience District, has dedicated scientists on staff devoted to finding effective cancer therapies quickly and cost-effectively.

Universities, investigators, foundations and companies bring their discoveries to the CRI to complete the necessary steps for introducing new treatments to the clinic:

  • Preclinical work to establish the therapeutic index
  • Process development to determine the standard operating procedure for manufacture
  • Drug production for clinical use
  • Quality control analyses of vialed agents
  • Formal pharmacology and toxicology studies
  • Investigational new drug application documentation
  • Phase I clinical trial management and subject care

Graduate students, physician fellows and biotechnology/biomedical students receive advanced training at the CRI.

With our focus, experience and close working relationships with regulatory groups, the Institute provides immense benefits to patients, national and international research sponsors and the clinical community.

Cancer Developmental Therapeutics

The Developmental Therapeutics (DT) program conducts research aimed at new drug and treatment development.

Scott & White Cancer Research Institute Receives $3.5 Million Grant

Only Central Texas cancer research program receiving award from Cancer Prevention Research Institute of Texas